We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+13.05%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$184M
AUM Growth
+$18.1M
Cap. Flow
-$1.79M
Cap. Flow %
-0.97%
Top 10 Hldgs %
39.57%
Holding
107
New
7
Increased
14
Reduced
32
Closed
3

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$556K
2
CBU icon
Community Bank
CBU
+$194K
3
FCX icon
Freeport-McMoran
FCX
+$148K
4
AMD icon
Advanced Micro Devices
AMD
+$58.3K
5
TRP icon
TC Energy
TRP
+$47.4K

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$633K
2
DHR icon
Danaher
DHR
+$610K
3
IFF icon
International Flavors & Fragrances
IFF
+$390K
4
KVUE icon
Kenvue
KVUE
+$312K
5
DE icon
Deere & Co
DE
+$143K

Sector Composition

Rank Sector Weight
1 Technology 22.95%
2 Industrials 17.98%
3 Healthcare 16.66%
4 Financials 15.8%
5 Consumer Staples 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
26
RTX Corp
RTX
$287B
$2.52M 1.37%
29,973
– –
VGR
27
DELISTED
Vector Group Ltd.
VGR
$2.49M 1.35%
221,030
– –
MLM icon
28
Martin Marietta Materials
MLM
$33.6B
$2.37M 1.28%
4,745
– –
V icon
29
Visa
V
$677B
$2.35M 1.28%
9,028
-100
-1% -$24.6K
CVS icon
30
CVS Health
CVS
$137B
$2.21M 1.2%
28,015
+270
+1% +$19.2K
LMT icon
31
Lockheed Martin
LMT
$134B
$2.2M 1.19%
4,855
-30
-0.6% -$13.3K
SYF icon
32
Synchrony
SYF
$23.7B
$2.09M 1.14%
54,827
– –
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$121B
$2.09M 1.13%
5,135
+100
+2% +$36.9K
BAM icon
34
Brookfield Asset Management
BAM
$74B
$2.03M 1.1%
50,623
-300
-0.6% -$10.1K
CI icon
35
Cigna
CI
$76.6B
$1.81M 0.98%
6,060
-49
-0.8% -$14.3K
TRP icon
36
TC Energy
TRP
$73.5B
$1.73M 0.94%
44,117
+1,300
+3% +$47.4K
QCOM icon
37
Qualcomm
QCOM
$176B
$1.66M 0.9%
11,496
-99
-0.9% -$12.3K
AMZN icon
38
Amazon
AMZN
$2.5T
$1.61M 0.88%
10,625
– –
J icon
39
Jacobs Solutions
J
$15.9B
$1.6M 0.87%
14,942
– –
MRNA icon
40
Moderna
MRNA
$21.5B
$1.43M 0.77%
14,362
– –
STZ icon
41
Constellation Brands
STZ
$22.2B
$1.31M 0.71%
5,433
-49
-0.9% -$11.7K
MRK icon
42
Merck
MRK
$324B
$1.29M 0.7%
11,825
+2
+0% +$208
COO icon
43
Cooper Companies
COO
$13.7B
$1.27M 0.69%
13,440
+120
+0.9% +$10.1K
JNJ icon
44
Johnson & Johnson
JNJ
$635B
$1.23M 0.67%
7,842
-199
-2% -$30.5K
PRU icon
45
Prudential Financial
PRU
$41.7B
$1.21M 0.66%
11,652
-196
-2% -$18.8K
CARR icon
46
Carrier Global
CARR
$57.2B
$1.1M 0.6%
19,178
+1
+0% +$53
MDT icon
47
Medtronic
MDT
$107B
$1.06M 0.57%
12,860
– –
HSY icon
48
Hershey
HSY
$35.4B
$1.04M 0.57%
5,588
+2
+0% +$379
DENN
49
DELISTED
Denny's
DENN
$1M 0.54%
92,136
– –
ORCL icon
50
Oracle
ORCL
$331B
$957K 0.52%
9,081
– –
1
2
3 4 5

Similar funds

VEA
Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return

Lipe & Dalton's Q4 2023 Portfolio in Review

As of Q4 2023, Lipe & Dalton held 107 positions worth $184M, up 11% from $166M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Lipe & Dalton's Q4 2023 filing shows 7 new, 14 increased, 32 reduced and 3 closed positions. Its largest new stake was Veralto: 7,442 shares worth $612K. The largest sale was Charles Schwab, an estimated $633K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Healthcare.

  • Lipe & Dalton's largest Q4 2023 buy was Veralto: 7,442 shares worth $612K.
  • Lipe & Dalton added most to TC Energy in Q4 2023, an estimated $47.4K increase.
  • Lipe & Dalton's biggest Q4 2023 reduction was Danaher, cutting an estimated $610K.
  • Lipe & Dalton fully exited Charles Schwab in Q4 2023, selling an estimated $633K.
  • Lipe & Dalton's ten largest holdings make up 40% of its $184M portfolio in Q4 2023.
  • Lipe & Dalton opened 7 new positions and closed 3 in Q4 2023.
  • Lipe & Dalton's portfolio value rose 11% quarter-over-quarter to $184M.

Based on Lipe & Dalton's 13F filing for Q4 2023, filed 30 Jan 2024.